Making Clinical Trials Better for Everyone in 2023

Getting clinical trials to the finish line is not easy. Between 15% to 40% ...

Two Key Questions About Clinical Trials in 2023

PM360 asked experts in clinical trials about the evolution of decentralized research and what ...

What Does It Take to Design a Patient-centric Clinical Trial Protocol?

Clinical trial protocol writing teams usually start with scientific objectives, and ideally with the ...

Evolution of ePROM: Advancements, Concerns, and the Way Forward

Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for ...

Deploying AI for Greater Efficiency in Clinical Trial Recruitment

Clinical trial recruitment is a lengthy and complex process involving stringent protocols and the ...

Digital Therapeutics Companies Lean into Decentralized Clinical Trials

While digital therapeutics (DTx) companies are extremely optimistic about the promise of software-based interventions ...

PM360 Q&A with Victoria Donovan, Founder and CEO, Clinically Media

As with many other areas of healthcare, COVID-19 has accelerated the transformation of clinical ...

Enhancing Patient Access and Retention in Rare Disease Clinical Trials

Rare diseases were in the spotlight recently when an early-stage clinical trial involving gene-editing ...

The Future of Clinical Trials is Here Today

The healthcare industry’s traditional model for medical research long has been costly, slow, and ...